Advances in targeted drug delivery system and applications

Read full text Summarise with VIRAT
Authors: {"name":"Kunda varalakshmi","email":"varalukunda@gmail.com","affiliation":", {"name":"Sarvepalli Revathi","email":"varalukunda@gmail.com","affiliation":"Depa, {"name":"Battala Divya","email":"varalukunda@gmail.com","affiliation":"IV Yea, {"name":"Katta sai manu","email":"varalukunda@gmail.com","affiliation":"IV, {"name":"K charunya","email":"varalukunda@gmail.com","affiliation":"IV, {"name":"Ediga vardhan","email":"varalukunda@gmail.com","affiliation":"IV Y, {"name":"Venugopalaiah Penabaka","email":"varalukunda@gmail.com","affiliation":"Dep, {"name":"Yadala prapurna chandra","email":"varalukunda@gmail.com","affiliati
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Targeted drug delivery systems (TDDS) represent a groundbreaking advancement in pharmaceutical science, aiming to enhance therapeutic efficacy and reduce side effects compared to conventional drug delivery methods. Unlike traditional systems, which distrib ute drugs non - selectively throughout the body, TDDS are designed to deliver drugs specifically to diseased tissues or cells, such as cancerous tumors or inflamed areas, thus minimizing systemic toxicity. This selective targeting is achieved through strateg ies like ligand - receptor interactions, pH - sensitive carriers, and nanoparticle - based vectors, including liposomes, dendrimers, and polymeric nanoparticles. Recent innovations in nanotechnology, biotechnology, and molecular biology have significantly enhanc ed the precision and efficiency of these systems. Active targeting mechanisms utilize ligands such as antibodies, peptides, or aptamers that bind to specific markers on target cells, while passive targeting leverages the enhanced permeability and retention (EPR) effect in tumors. The integration of stimuli - responsive materials allows for controlled drug release triggered by factors like pH, temperature, enzymes, or magnetic fields. Despite challenges in biocompatibility, scalability, and regulatory approval , ongoing research continues to improve the safety, specificity, and clinical applicability of TDDS, positioning them as essential tools for treating chronic diseases like cancer, cardiovascular disorders, and autoimmune conditions.

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Advanced Drug Delivery Systems Dendrimers and Hyperbranched Polymers

Publication details

Journal / source
International Journal of Clinical Pharmacokinetics and Medical Sciences
Volume
6
Issue
1
Pages
52–62
Publication date
12 February 2026
Language
EN